Global Analytical Instrumentation Market in Pharmaceuticals, Biopharmaceuticals, and Nutraceuticals, Forecast to 2025

Global Analytical Instrumentation Market in Pharmaceuticals, Biopharmaceuticals, and Nutraceuticals, Forecast to 2025

Growth of Biosimilars and Nutraceuticals will Drive Growth

RELEASE DATE
17-Oct-2019
REGION
Global
Research Code: K3BA-01-00-00-00
SKU: TM00605-GL-MR_23677

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
TM00605-GL-MR_23677

$4,950.00

$3,712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The global pharmaceuticals, biopharmaceuticals, and neutraceuticals market includes market revenues of analytical instrumentation applied in the 3 segments. Analytical instruments are applied in research, development, manufacturing, quality control, and distribution of drugs. Some key applications include (and are not limited to) drug discovery and development testing, biopharmaceutical analytical testing, quality control testing, cancer research, and process technology analysis.

Neutraceutical includes analytical equipment used for functional food and beverages, dietary supplements, and herbals. Geographic scope is global. Different techniques, including chromatographs, mass spectrometers, infrared spectrometers, UV-Vis spectrometers, Raman spectrometers, thermal analyzers, and X-ray diffractometers are included under different applications. The total analytical instrumentation market in pharmaceuticals, biopharmaceuticals, and neutraceuticals was estimated at $3056.7 million in 2018, and is expected to reach $4911.4 million in 2025. There is a high pricing pressure on drug manufacturers to cut down costs. Hence, manufacturers would have to create a flexible pricing strategy to maximize their profits and negotiate with payers. Process analyzers that can be plugged in as part of the manufacturing process would reduce operating costs for manufacturers.

The pharmaceutical market in 2018 oversaw massive vertical integration of organizations. This would lead to cost efficiency and innovation in the industry.

Asia-Pacific is a large focus for pharmaceutical manufacturers, especially China. China has become a hub for innovation and R&D.

With the increasing approval for biosimilars in the United States, there would be significant cost cuts in the country, motivated by government institutions such as the National Health Service (NHS). The price differential between biosimilars and their branded counterparts is 30%. US political uncertainity and Brexit would negatively impact pharmaceutical market growth.

Manufacturers are offering exclusive biopharmaceutical solutions to resolve challenges associated with biological drugs. The intention of avoiding side effects-imposing small molecules and complex surgical procedures has led to targeted therapies of biologics. By 2020, analysts will expect biological drugs to capture about a quarter of the total small molecules market.

Growth of biological drugs is expected to continue, as biological blockbuster drugs keep entering the market. The penetration of biologic drugs will increase from 25% in 2016 to 30% in 2022.

Neutraceuticals are gaining importance and becoming a part of consumers’ daily diet. Lifestyle, health disorders, and lack of exercise are leading to the segment’s growth. Ingredients and raw material contamination, less awareness, and unclear regulations are challenging market growth.

Neutraceuticals are often dietary supplements or food additives. They offer benefits such as preventing and curing diseases. Functional beverages such as energy drinks that contain stimulants to make the brain active are also popular.

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Key Findings

Market Engineering Measurements

Market Engineering Measurements (continued)

CEO’s Perspective

Market Scope and Definitions

Key Questions this Study will Answer

Market Segmentation

Market Drivers

Drivers Explained

Drivers Explained (continued)

Drivers Explained (continued)

Market Restraints

Restraints Explained

Market Engineering Measurements

Market Engineering Measurements (continued)

Forecast Assumptions

Revenue Forecast

Revenue Forecast Discussion

Pricing Analysis

Percent Revenue Forecast by Region

Revenue Forecast by Region

Top Trends in North America

Top Trends in Europe

Top Trends in Asia-Pacific

Top Trends in ROW

Revenue Forecast by Vertical Market

Top Competitors

Product Highlights

Growth Opportunity 1—Neutraceuticals

Growth Opportunity 2—Biosimilars

Strategic Imperatives for Success and Growth

Key Findings

Market Engineering Measurements

Revenue Forecast

Revenue Forecast Discussion

Revenue Forecast by Product

Revenue Forecast Discussion by Product

Market Share

Market Share Analysis

Market Share Analysis (continued)

Competitive Environment

Key Findings

Market Engineering Measurements

Revenue Forecast

Revenue Forecast Discussion

Revenue Forecast by Product

Revenue Forecast Discussion by Product

Market Share

Market Share Analysis

Market Share Analysis (continued)

Competitive Environment

Key Findings

Market Engineering Measurements

Revenue Forecast

Revenue Forecast Discussion

Revenue Forecast by Product

Revenue Forecast Discussion by Product

Market Share

Market Share Analysis

Competitive Environment

Key Findings

Revenue Forecast

Revenue Forecast Discussion

Revenue Forecast by Vertical Market

Revenue Forecast Discussion by Vertical Market

Market Segmentation—Pharmaceuticals

Market Segmentation—Biopharmaceuticals

Market Segmentation—Neutraceuticals

Market Share

Market Share Analysis

Competitive Environment

The Last Word—3 Big Predictions

Legal Disclaimer

Market Engineering Methodology

Additional Sources of Information on Study Topic

List of Companies in “Others”

Partial List of Companies Interviewed

List of Exhibits

List of Exhibits (continued)

List of Exhibits (continued)

Related Research
The global pharmaceuticals, biopharmaceuticals, and nutraceuticals market includes market revenues of analytical instrumentation applied in the 3 segments. Analytical instruments are applied in research, development, manufacturing, quality control, and distribution of drugs. Some key applications include (and are not limited to) drug discovery and development testing, biopharmaceutical analytical testing, quality control testing, cancer research, and process technology analysis. Nutraceutical includes analytical equipment used for functional food and beverages, dietary supplements, and herbals. Geographic scope is global. Different techniques, including chromatographs, mass spectrometers, infrared spectrometers, UV-Vis spectrometers, Raman spectrometers, thermal analyzers, and X-ray diffractometers are included under different applications. The total analytical instrumentation market in pharmaceuticals, biopharmaceuticals, and nutraceuticals was estimated at $3056.7 million in 2018, and is expected to reach $4911.4 million in 2025. There is a high pricing pressure on drug manufacturers to cut down costs. Hence, manufacturers would have to create a flexible pricing strategy to maximize their profits and negotiate with payers. Process analyzers that can be plugged in as part of the manufacturing process would reduce operating costs for manufacturers. The pharmaceutical market in 2018 oversaw massive vertical integration of organizations. This would lead to cost efficiency and innovation in the industry. Asia-Pacific is a large focus for pharmaceutical manufacturers, especially China. China has become a hub for innovation and R&D. With the increasing approval for biosimilars in the United States, there would be significant cost cuts in the country, motivated by government institutions such as the National Health Service (NHS). The price differential between biosimilars and their branded counterparts is 30%. US political uncertainity and Brexit would negatively impact pharmaceutical market growth. Manufacturers are offering exclusive biopharmaceutical solutions to resolve challenges associated with biological drugs. The intention of avoiding side effects-imposing small molecules and complex surgical procedures has led to targeted therapies of biologics. By 2020, analysts will expect biological drugs to capture about a quarter of the total small molecules market. Growth of biological drugs is expected to continue, as biological blockbuster drugs keep entering the market. The penetration of biologic drugs will increase from 25% in 2016 to 30% in 2022. Nutraceuticals are gaining importance and becoming a part of consumers’ daily diet. Lifestyle, health disorders, and lack of exercise are leading to the segment’s growth. Ingredients and raw material contamination, less awareness, and unclear regulations are challenging market growth. Nutraceuticals are often dietary supplements or food additives. They offer benefits such as preventing and curing diseases. Functional beverages such as energy drinks that contain stimulants to make the brain active are also popular.
More Information
No Index No
Podcast No
Author Janani Balasundar
Industries Test and Measurement Instrumentation
WIP Number K3BA-01-00-00-00
Is Prebook No
GPS Codes 9404-A5,9594,9ACC-A5